| Literature DB >> 35002387 |
Fulwah Y Alqahtani1, Safiah H Alattas1, Thamer A Almangour2, Fadilah S Aleanizy1.
Abstract
OBJECTIVES: Antimicrobial resistance is one of the main global problems faced by healthcare institutions. Healthcare professionals as service providers must have a basic understanding of this emerging threat; additionally, considering the evolving role of pharmacists in both the community and hospital setting, it is crucial that pharmacists are part of the fight against this threat. Therefore, this study aimed to assess infectious disease subjects covered in the pharmacy curriculum in Saudi Arabia, to evaluate teaching and knowledge assessment strategies concerning infectious diseases, and to explore challenges faced by faculty members in teaching infectious disease courses.Entities:
Keywords: Antimicrobial stewardship; Infectious disease; Pharmacy curriculum; Saudi Arabia
Year: 2021 PMID: 35002387 PMCID: PMC8720813 DOI: 10.1016/j.jsps.2021.11.009
Source DB: PubMed Journal: Saudi Pharm J ISSN: 1319-0164 Impact factor: 4.330
Fig. 1Responses received from participating Saudi pharmacy colleges.
Details of the pharmacy degrees offered by the included colleges.
| % | ||
|---|---|---|
| Professional degree offered | Doctor of Pharmacy (PharmD) | 67.3 |
| Bachelor of Pharmaceutical Science (BSc) | 12.7 | |
| Both | 20.0 | |
| Length of curriculum | 5 years | 27.3 |
| 6 years | 61.8 | |
| Both for dual-degree programs | 10.9 | |
| Format of the academic curriculum schedule | Semester | 98.2 |
| Block | 1.8 | |
Required and elective infectious disease topics covered in the pharmaceutical curricula followed by the included colleges
| Required Topics | Elective Topics | None | ||||
|---|---|---|---|---|---|---|
| Number | % | Number | % | Number | % | |
| Urinary tract infections, uncomplicated | 50 | 90.9 | 0 | 0 | 5 | 9.1 |
| Antimicrobial regimen selection | 51 | 92.7 | 1 | 1.8 | 3 | 5.5 |
| Fungal infections, superficial | 50 | 90.9 | 2 | 3.6 | 3 | 5.5 |
| Lower respiratory tract infections | 49 | 89.1 | 1 | 1.8 | 5 | 9.1 |
| Skin and soft tissue infections | 45 | 81.8 | 1 | 1.8 | 9 | 16.4 |
| Upper respiratory tract infections | 48 | 87.3 | 2 | 3.6 | 5 | 9.1 |
| Influenza virus infection | 44 | 80 | 5 | 9.1 | 6 | 10.9 |
| 43 | 78.2 | 3 | 5.5 | 9 | 16.4 | |
| Immunization | 46 | 83.6 | 3 | 5.5 | 6 | 10.9 |
| Human immunodeficiency virus infection | 48 | 87.3 | 2 | 3.6 | 5 | 9.1 |
| Tuberculosis | 52 | 94.5 | 1 | 1.8 | 2 | 3.6. |
| Sexually transmitted infections | 41 | 74.5 | 5 | 9.1 | 9 | 16.4 |
| Central nervous system infections | 44 | 80 | 2 | 3.6 | 9 | 16.4 |
| Hepatitis, viral | 51 | 92.7 | 1 | 1.8 | 3 | 5.5 |
| Urinary tract infections, complicated# | 46 | 83.6 | 1 | 1.8 | 8 | 14.5 |
| Fungal infections, invasive | 47 | 85.5 | 2 | 3.6 | 6 | 10.9 |
| Infections in immunocompromised patients | 37 | 67.3 | 3 | 5.5 | 15 | 27.3 |
| Infective endocarditis | 41 | 74.5 | 3 | 5.5 | 11 | 20 |
| Intra-abdominal infections | 40 | 72.7 | 3 | 5.5 | 12 | 21.8 |
| Sepsis and septic shock | 42 | 76.4 | 2 | 3.6 | 11 | 20 |
| Bone and joint infections | 32 | 58.2 | 3 | 5.5 | 20 | 36.4 |
| Bacterial resistance | 46 | 83.6 | 4 | 7.3 | 5 | 9.1 |
| Microbiology labs | 47 | 85.5 | 2 | 3.6 | 6 | 10.9 |
| Gastrointestinal infections | 41 | 74.5 | 2 | 3.6 | 12 | 21.8 |
| Antimicrobial stewardship | 35 | 63.6 | 3 | 5.5 | 17 | 30.9 |
| Bloodstream and catheter infections | 36 | 65.5 | 4 | 7.3 | 15 | 27.3 |
| Antimicrobial prophylaxis in surgery and other procedures | 33 | 60 | 7 | 12.7 | 15 | 27.3 |
| Parasitic diseases | 39 | 70.9 | 3 | 5.5 | 13 | 23.6 |
| Prostatitis | 26 | 47.3 | 6 | 10.9 | 23 | 41.8 |
| Tickborne illnesses | 26 | 47.3 | 5 | 9.1 | 24 | 43.6 |
| Health care–acquired infections: preventive measures | 36 | 65.5 | 2 | 3.6 | 17 | 30.9 |
| Travel medicine | 19 | 34.5 | 6 | 10.9 | 30 | 54.5 |
| Spirochaetal diseases | 30 | 54.5 | 5 | 9.1 | 20 | 36.4 |
| Mycobacterial infections, non-tuberculosis | 32 | 58.2 | 4 | 7.3 | 19 | 34.5 |
| Viral infections, miscellaneous | 51 | 92.7 | 2 | 3.6 | 2 | 3.6 |
| Bacterial infections, miscellaneous | 51 | 92.7 | 1 | 1.8 | 3 | 5.5 |
*Significant differences (p < 0.05) between male and female sex.
#Significant differences (p < 0.05) between types of academic institutions—government vs. private.
Time dedicated to each infectious disease topic offered as part of the pharmaceutical curricula by the included colleges
| 1 Hour | 2 Hours | 3 Hours | ≥ 3 Hours | |||||
|---|---|---|---|---|---|---|---|---|
| No. | % | No. | % | No. | % | No. | % | |
| Urinary tract infections, uncomplicated | 27 | 49.09 | 15 | 27.27 | 11 | 20 | 2 | 3.64 |
| Antimicrobial regimen selection | 17 | 30.91 | 20 | 36.36 | 14 | 25.45 | 4 | 7.27 |
| Fungal infections, superficial | 31 | 56.36 | 12 | 21.82 | 10 | 18.18 | 2 | 3.64 |
| Lower respiratory tract infections | 18 | 32.73 | 23 | 41.82 | 9 | 16.36 | 5 | 9.09 |
| Skin and soft tissue infections | 21 | 38.18 | 18 | 32.73 | 12 | 21.82 | 4 | 7.27 |
| Upper respiratory tract infections | 23 | 41.82 | 19 | 34.55 | 9 | 16.36 | 4 | 7.27 |
| Influenza virus infection | 31 | 56.36 | 15 | 27.27 | 9 | 16.36 | 0 | 0 |
| 29 | 52.73 | 10 | 18.18 | 15 | 27.27 | 1 | 1.82 | |
| Immunization | 18 | 32.73 | 22 | 40 | 11 | 20 | 4 | 7.27 |
| Human immunodeficiency virus infection | 24 | 43.64 | 16 | 29.09 | 12 | 21.82 | 3 | 5.45 |
| Tuberculosis | 20 | 36.36 | 24 | 43.64 | 8 | 14.55 | 3 | 5.45 |
| Sexually transmitted infections | 20 | 36.36 | 17 | 30.91 | 16 | 29.09 | 2 | 3.64 |
| Central nervous system infections | 18 | 32.73 | 16 | 29.09 | 17 | 30.91 | 4 | 7.27 |
| Hepatitis, viral | 20 | 36.36 | 21 | 38.18 | 8 | 14.55 | 6 | 10.91 |
| Urinary tract infections, complicated | 28 | 50.91 | 16 | 29.09 | 11 | 20 | 0 | 0 |
| Fungal infections, invasive | 28 | 50.91 | 10 | 18.18 | 11 | 20 | 6 | 10.91 |
| Infections in immunocompromised patients | 25 | 45.45 | 11 | 20 | 16 | 29.09 | 3 | 5.45 |
| Infective endocarditis | 21 | 38.18 | 13 | 23.64 | 18 | 32.73 | 3 | 5.45 |
| Intra-abdominal infections | 24 | 43.64 | 13 | 23.64 | 16 | 29.09 | 2 | 3.64 |
| Sepsis and septic shock | 19 | 34.55 | 15 | 27.27 | 16 | 29.09 | 5 | 9.09 |
| Bone and joint infections | 20 | 36.36 | 12 | 21.82 | 21 | 38.18 | 2 | 3.64 |
| Bacterial resistance | 21 | 38.18 | 16 | 29.09 | 12 | 21.82 | 6 | 10.91 |
| Microbiology labs | 12 | 21.82 | 18 | 32.73 | 10 | 18.18 | 15 | 27.27 |
| Gastrointestinal infections | 18 | 32.73 | 18 | 32.73 | 16 | 29.09 | 3 | 5.45 |
| Antimicrobial stewardship | 17 | 30.91 | 17 | 30.91 | 20 | 36.36 | 1 | 1.82 |
| Bloodstream and catheter infections# | 21 | 38.18 | 14 | 25.45 | 20 | 36.36 | 0 | 0 |
| Antimicrobial prophylaxis in surgery and other procedures * | 24 | 43.64 | 12 | 21.82 | 18 | 32.73 | 1 | 1.82 |
| Parasitic diseases | 18 | 32.73 | 16 | 29.09 | 13 | 23.64 | 8 | 14.55 |
| Prostatitis# | 25 | 45.45 | 6 | 10.91 | 22 | 40 | 2 | 3.64 |
| Tickborne illnesses# | 23 | 41.82 | 8 | 14.55 | 24 | 43.64 | 0 | 0 |
| Health care–acquired infections: preventive measures# | 26 | 47.27 | 13 | 23.64 | 16 | 29.09 | 0 | 0 |
| Travel medicine# | 21 | 38.18 | 6 | 10.91 | 27 | 49.09 | 1 | 1.82 |
| Spirochaetal diseases# | 23 | 41.82 | 10 | 18.18 | 22 | 40 | 0 | 0 |
| Mycobacterial infections, non-tuberculosis# | 26 | 47.27 | 10 | 18.18 | 19 | 34.55 | 0 | 0 |
| Viral infections, miscellaneous | 14 | 25.45 | 22 | 40 | 8 | 14.55 | 11 | 20 |
| Bacterial infections, miscellaneous | 9 | 16.36 | 22 | 40 | 8 | 14.55 | 16 | 29.09 |
*Significant differences (p < 0.05) between academic positions.
#Significant differences (p < 0.05) between types of academic institutions—governmental vs. private.
Teaching tools utilized in the classroom to deliver infectious disease lectures at the included colleges
| Strategy | Consistently Used | Frequently Used | Rarely Used | Never Used | ||||
|---|---|---|---|---|---|---|---|---|
| No. | % | No. | % | No. | % | No. | % | |
| Lectures | 52 | 94.5 | 3 | 5.5 | 0 | 0 | 0 | 0 |
| Laboratories | 29 | 52.7 | 20 | 36.4 | 3 | 5.5 | 3 | 5.5 |
| Demonstration | 16 | 29.1 | 26 | 47.3 | 12 | 22 | 1 | 1.8 |
| Active learning | 25 | 45.5 | 14 | 25.5 | 15 | 27 | 1 | 1.8 |
| Patient case application | 30 | 54.5 | 16 | 29.1 | 7 | 13 | 2 | 3.6 |
| Audience response systems# | 14 | 25.5 | 15 | 27.3 | 15 | 27 | 11 | 20 |
| Student-generated questions | 12 | 21.8 | 27 | 49.1 | 12 | 22 | 4 | 7.3 |
| Simulation | 5 | 9.1 | 20 | 36.4 | 16 | 29 | 14 | 26 |
| Think, pair, share | 9 | 16.4 | 17 | 30.9 | 16 | 29 | 13 | 24 |
| Ungraded quizzes* | 15 | 27.3 | 13 | 23.6 | 16 | 29 | 11 | 20 |
| Muddiest point | 2 | 3.6 | 11 | 20 | 13 | 24 | 29 | 53 |
| Concept maps | 7 | 12.7 | 7 | 12.7 | 17 | 31 | 24 | 44 |
| Puzzles | 3 | 5.5 | 7 | 12.7 | 22 | 40 | 23 | 42 |
*Significant differences (p < 0.05) based on age.
#Significant differences (p < 0.05) between the male and female sex.